Product References — Proteins

In Vitro Validation Assessment of a Fecal Occult Blood Protein Test for Horses

Posted by Adam Awdish on

In Vitro Validation Assessment of a Fecal Occult Blood Protein Test for Horses

Horse Albumin Purified Lyophilized from Innovative Research was used in the following study:   In Vitro Validation Assessment of a Fecal Occult Blood Protein Test for Horses Irena Rebalka, PhD; Michael I. Lindinger, PhD Journal of Equine Veterinary Science June 25, 2021 Unlike omnivorous or carnivorous animals, the presence of blood proteins in the feces of herbivores is not normal. Herbivores normally don’t consume animal proteins in their foods, and they typically have GI tracts with tight barriers, so the chance of blood proteins to be present in fecal matter resulting from the animal’s diet or from a leaky gut...

Read more →

Associative Interactions among Zinc, Apolipoprotein E, and Amyloid-β in the Amyloid Pathology

Posted by Corey Marcath on

Associative Interactions among Zinc, Apolipoprotein E, and Amyloid-β in the Amyloid Pathology

Human Plasmin Purified from Innovative Research was used in the following study:   Associative Interactions among Zinc, Apolipoprotein E, and Amyloid-β in the Amyloid Pathology Shin Bi Oh, Jung Ah Kim, SuJi Park, and Joo-Yong Lee International Journal of Molecular Sciences 25 January 2020 “Zinc and apolipoprotein E (apoE) are reportedly involved in the pathology of Alzheimer’s disease. To investigate the associative interaction among zinc, apoE, and amyloid-β (Aβ) and its role in amyloid pathogenesis, we performed various biochemical and immunoreactive analyses using brain tissues of Tg2576 mice and synthetic Aβ and apoE peptides. …The protein pellets were resuspended and...

Read more →

B- and T-lymphocyte attenuator stimulation protects against atherosclerosis by regulating follicular B cells

Posted by Corey Marcath on

B- and T-lymphocyte attenuator stimulation protects against atherosclerosis by regulating follicular B cells

Hamster Armenian IgG Affinity Purified from Innovative Research was used in the following study:   B- and T-lymphocyte attenuator stimulation protects against atherosclerosis by regulating follicular B cells Hidde Douna, Jacob Amersfoort, Frank H. Schaftenaar, Mara J. Kro¨ ner, Ma´te´ G. Kiss, Bram Slu¨ tter, Marie A. C. Depuydt, Mireia N. A. Bernabe´ Kleijn, Anouk Wezel, Harm J. Smeets, Hideo Yagita, Christoph J. Binder, I. Bot,Gijs H. M. van Puijvelde, Johan Kuiper, and Amanda C. Foks European Society of Cardiology 10 May 2019 “…Inflammation is a key process in the development of atherosclerosis. Components of both the innate and adaptive...

Read more →

Suppression of Choroidal Neovascularization and Fibrosis by a Novel RNAi Therapeutic Agent against (Pro)renin Receptor

Posted by Corey Marcath on

Suppression of Choroidal Neovascularization and Fibrosis by a Novel RNAi Therapeutic Agent against (Pro)renin Receptor

Human Prorenin Native Recombinant from Innovative Research was used in the following study:   Suppression of Choroidal Neovascularization and Fibrosis by a Novel RNAi Therapeutic Agent against (Pro)renin Receptor Ye Liu, Atsuhiro Kanda, Di Wu, Erdal Tan Ishizuka, Satoru Kase, Kousuke Noda, Atsuhiro Ichihara, Susumu Ishida Molecular Therapy Nucleic Acids May 28, 2019 “…Age-related macular degeneration (AMD) is the leading cause of irreversible blindness worldwide. The wet (neovascular or exudative) type of AMD usually causes severe vision loss and is characterized by choroidal neovascularization (CNV), which extends from the choroid into the subretinal space and disrupts Bruch’s membrane and the...

Read more →

Suppression of Choroidal Neovascularization and Fibrosis by a Novel RNAi Therapeutic Agent against (Pro)renin Receptor

Posted by Corey Marcath on

Suppression of Choroidal Neovascularization and Fibrosis by a Novel RNAi Therapeutic Agent against (Pro)renin Receptor

Human Prorenin Native Recombinant from Innovative Research was used in the following study:   Suppression of Choroidal Neovascularization and Fibrosis by a Novel RNAi Therapeutic Agent against (Pro)renin Receptor Ye Liu, Atsuhiro Kanda, Di Wu, Erdal Tan Ishizuka, Satoru Kase, Kousuke Noda, Atsuhiro Ichihara, and Susumu Ishida Molecular Therapy Nucleic Acids May 28, 2019 ”…Age-related macular degeneration (AMD) is the leading cause of irreversible blindness worldwide.1 The wet (neovascular or exudative) type of AMD usually causes severe vision loss and is characterized by choroidal neovascularization (CNV), which extends from the choroid into the subretinal space and disrupts Bruch’s membrane and...

Read more →


×